Risk Factors for Serogroup B Meningococcal Disease Among College Students
- PMID: 38149105
- PMCID: PMC10750260
- DOI: 10.1093/ofid/ofad607
Risk Factors for Serogroup B Meningococcal Disease Among College Students
Abstract
Background: College students are at increased risk for invasive meningococcal disease, but which students are most at risk is unclear.
Methods: US meningococcal disease cases in persons aged 18-24 years during 2014-2017 were included. Patients were classified as undergraduate students or other persons. Incidence in different student and non-student populations was compared.
Results: During 2014-2017, 229 meningococcal disease cases were reported in persons aged 18-24 years; 120 were in undergraduate students. Serogroup B accounted for 74% of cases in students. Serogroup B disease incidence was 4-fold higher in undergraduate students, 11.8-fold higher among first-year undergraduate students, and 8.6-fold higher among residence hall residents versus non-undergraduates. During outbreaks, students affiliated with Greek life had a 9.8-fold higher risk of disease compared to other students. A significantly higher party school ranking was observed for schools with sporadic or outbreak cases when compared to schools with no cases.
Conclusions: The findings of increased disease risk among first-year students and those living on campus or affiliated with Greek life can inform shared clinical decision-making for serogroup B vaccines to prevent this rare but serious disease. These data also can inform school serogroup B vaccination policies and outbreak response measures.
Keywords: College students; MenB vaccine; Meningococcal disease.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest.
Figures


Similar articles
-
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.Hum Vaccin Immunother. 2019;15(4):978-986. doi: 10.1080/21645515.2018.1556074. Epub 2019 Jan 16. Hum Vaccin Immunother. 2019. PMID: 30526279 Free PMC article.
-
Serogroup B meningococcal vaccination practice patterns on college campuses.Vaccine. 2020 Oct 27;38(46):7350-7356. doi: 10.1016/j.vaccine.2020.09.035. Epub 2020 Oct 1. Vaccine. 2020. PMID: 33010977
-
Meningococcal Disease Among College-Aged Young Adults: 2014-2016.Pediatrics. 2019 Jan;143(1):e20182130. doi: 10.1542/peds.2018-2130. Pediatrics. 2019. PMID: 30598460
-
Lessons from mass vaccination response to meningococcal B outbreaks at US universities.Postgrad Med. 2020 Sep;132(7):614-623. doi: 10.1080/00325481.2020.1766265. Epub 2020 Jun 1. Postgrad Med. 2020. PMID: 32476532 Review.
-
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.Vaccine. 2016 Feb 10;34(7):875-80. doi: 10.1016/j.vaccine.2015.11.057. Epub 2015 Dec 10. Vaccine. 2016. PMID: 26686570 Review.
Cited by
-
Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States.Pharmacoeconomics. 2025 Mar;43(3):311-329. doi: 10.1007/s40273-024-01439-y. Epub 2024 Nov 25. Pharmacoeconomics. 2025. PMID: 39585581 Free PMC article.
-
Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.Hum Vaccin Immunother. 2024 Dec 31;20(1):2406613. doi: 10.1080/21645515.2024.2406613. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39373020 Free PMC article.
-
Meningococcal Vaccination in the United States: Past, Present, And Future.Paediatr Drugs. 2025 May;27(3):331-349. doi: 10.1007/s40272-024-00666-2. Epub 2025 Feb 20. Paediatr Drugs. 2025. PMID: 39979767 Review.
References
-
- Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine 2012; 30(Suppl 2):B3–9. - PubMed
-
- MacNeil JR, Blain AE, Wang X, Cohn AC. Current epidemiology and trends in meningococcal disease—United States, 1996–2015. Clin Infect Dis 2018; 66:1276–81. - PubMed
-
- Centers for Disease Control and Prevention . Meningococcal disease surveillance. 2022. Available at: https://www.cdc.gov/meningococcal/surveillance/index.html. Accessed 9 February 2023.
-
- Centers for Disease Control and Prevention . Enhanced meningococcal disease surveillance report, 2018. Available at: https://www.cdc.gov/meningococcal/downloads/ncird-ems-report-2018.pdf. Accessed 9 February 2023.
-
- Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal disease among college-aged young adults: 2014–2016. Pediatrics 2019; 143:e20182130. - PubMed